Tesamorelin Description: A growth hormone-releasing peptide that targets visceral fat, especially in the abdominal area, while supporting metabolic health
AOD9604 vs CJC-1295: What the Evidence Shows AOD9604 vs CJC-1295: see what published clinical trials actually found on fat loss, GH/IGF-1 effects, safety, and U.S
In diet-induced obese (DIO) mouse models, NNMT inhibition with 5-Amino-1MQ was associated with reduced white adipose tissue mass without affecting food intake, suggesting changes in energy expenditure rather than appetite suppression
Cox, Daniel Eichner Published: Drug Testing and Analysis, Volume 7, Issue 1, January 2015, pages 3138 DOI: 10.1002/dta.1715 URL: AOD9604 was incubated in human serum and rat plasma at room temperature to study in vitro metabolic degradation
This means understanding that sometimes, gaining weight healthily isn't just about eating more calories